An experimental liver-growing treatment is facing its biggest test in humans yet. This week, biotech company LyGenesis announced that it has just begun a phase II trial of its therapy designed to grow miniature livers inside a person’s lymph nodes. If the therapy works as hoped, it could potentially save the lives of…
